130
Participants
Start Date
March 26, 2018
Primary Completion Date
November 30, 2019
Study Completion Date
November 30, 2019
S-1
Intervention is administered to patients in this Arm.
Leucovorin(oral )
Intervention is administered to patients in this Arm.
Gemcitabine
Intervention is administered to patients in this Arm.
Oxaliplatin
Intervention is administered to patients in this Arm.
Irinotecan
Intervention is administered to patients in this Arm.
5-FU
Intervention is administered to patients in this Arm.
Leucovorin(IV)
Intervention is administered to patients in this Arm.
National Institute of Cancer Research, Miaoli
National Taiwan University Hospital
OTHER
Taipei Veterans General Hospital, Taiwan
OTHER_GOV
China Medical University Hospital
OTHER
National Cheng-Kung University Hospital
OTHER
Kaohsiung Medical University
OTHER
Taipei Medical University Shuang Ho Hospital
OTHER
Chang Gung Memorial Hospital
OTHER
Tri-Service General Hospital
OTHER
E-DA Hospital
OTHER
National Health Research Institutes, Taiwan
OTHER